QCM
HRMY icon

Quantinno Capital Management’s Harmony Biosciences HRMY Stock Holding History

Quantinno Capital Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$527K Buy
14,477
+843
+6% +$26.6K ﹤0.01% 2955
2026
Q1 		$382K Buy
13,634
+1,361
+11% +$44.6K ﹤0.01% 2899
2025
Q4 		$459K Sell
12,273
-505
-4% -$16.6K ﹤0.01% 2510
2025
Q3 		$352K Buy
12,778
+3,788
+42% +$130K ﹤0.01% 2320
2025
Q2 		$284K Buy
+8,990
New +$289K ﹤0.01% 2071

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quantinno Capital Management's HRMY Position: Q2 2026 in Review

Quantinno Capital Management increased its Harmony Biosciences (HRMY) stake by 6.2% in Q2 2026, buying an estimated $26.6K and bringing the position to 14,477 shares worth $527K. The position accounts for ﹤0.01% of the portfolio, ranked #2955.

Quantinno Capital Management first reported a position in HRMY in Q2 2025 and has held it in 5 quarters since. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Quantinno Capital Management held 14,477 shares of Harmony Biosciences worth $527K as of Q2 2026.
  • Quantinno Capital Management bought 843 Harmony Biosciences shares in Q2 2026, an estimated $26.6K.
  • Harmony Biosciences made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #2955 holding.
  • Quantinno Capital Management first reported a position in Harmony Biosciences in Q2 2025 and has held it in 5 quarters since.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.